Evidence map›Paper›PMID 36008958›Full record

ArticleBiomolecules2022

Bioimprinting as a Receptor for Detection of Kwakhurin.

Seiichi Sakamoto, Kei Minami, Poomraphie Nuntawong, Gorawit Yusakul, Waraporn Putalun, Hiroyuki Tanaka, Shunsuke Fujii, Satoshi Morimoto

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Frontiers in pharmacology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Seiichi SakamotoGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.ORCID 0000-0001-6871-522X
Kei MinamiGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Poomraphie NuntawongGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Gorawit YusakulSchool of Pharmacy, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Waraporn PutalunFaculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
Hiroyuki TanakaFaculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori, Yamaguchi 756-0884, Japan.
Shunsuke FujiiFaculty of Health Management, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.
Satoshi MorimotoGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Kyushu University · JPKhon Kaen University · THNagasaki International University · JPSanyo-Onoda City University · JPWalailak University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioimprinting was performed against ovalbumin (OVA) to confer its binding cavities for kwakhurin (Kwa), an isoflavonoid, produced solely by

Indexed as

IsoflavonesPuerariaAntibodies, MonoclonalEnzyme-Linked Immunosorbent AssayOvalbuminReproducibility of ResultsAntibodies, MonoclonalIsoflavoneskwakhurinOvalbuminbioimprintingenzyme-linked bioimprinted-protein assay (ELBIA)enzyme-linked immunosorbent assay (ELISA)kwakhurin (Kwa)monoclonal antibody (MAb)ovalbumin (OVA)

Identifiers

PMID36008958
PMCPMC9405580
OpenAlexW4289335615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.